Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Brookline Capital Initiates Coverage On Intellia Therapeutics with Hold Rating

Brookline Capital initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Hold rating.
byBenzinga Newsdesk
February 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Brookline Capital initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Hold rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts